HEADER TRANSFERASE/TRANSFERASE INHIBITOR 20-JUL-16 5KX7 TITLE IRAK4-INHIBITOR CO-STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 160-460); COMPND 5 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE, PHOSPHATASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.O.FISCHMANN REVDAT 2 24-AUG-16 5KX7 1 JRNL REVDAT 1 17-AUG-16 5KX7 0 JRNL AUTH J.HANISAK,W.M.SEGANISH,W.T.MCELROY,H.TANG,R.ZHANG,H.C.TSUI, JRNL AUTH 2 T.FISCHMANN,D.TULSHIAN,J.TATA,C.SONDEY,K.DEVITO,J.FOSSETTA, JRNL AUTH 3 C.G.GARLISI,D.LUNDELL,X.NIU JRNL TITL EFFORTS TOWARDS THE OPTIMIZATION OF A BI-ARYL CLASS OF JRNL TITL 2 POTENT IRAK4 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 26 4250 2016 JRNL REFN ESSN 1464-3405 JRNL PMID 27476420 JRNL DOI 10.1016/J.BMCL.2016.07.048 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 17591 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 871 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.71 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2785 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2600 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2643 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE : 0.3330 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4135 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 79.88 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 92.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.25220 REMARK 3 B22 (A**2) : -42.54730 REMARK 3 B33 (A**2) : 37.29510 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.420 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 1.142 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.333 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.895 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.870 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8278 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 14953 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1859 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 120 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1211 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 8278 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 556 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 9054 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.88 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.71 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KX7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1000222861. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS SEPTEMBER 26, 2012 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.9 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17664 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.796 REMARK 200 RESOLUTION RANGE LOW (A) : 39.317 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : 0.07700 REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.81000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.80 TO 2.0 M SODIUM MALONATE, 0.2 M REMARK 280 SODIUM ACETATE, 25 MM HEXAMMINECOBALT(III)CHLORIDE, 0.05%W/V REMARK 280 PLURONIC-F-68, PH 6.4, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.90000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 57.14000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 69.72000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.90000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 57.14000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 69.72000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.90000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 57.14000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 69.72000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.90000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 57.14000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 69.72000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 THR A 163 REMARK 465 ARG A 164 REMARK 465 PHE A 165 REMARK 465 HIS A 166 REMARK 465 SER A 167 REMARK 465 PHE A 168 REMARK 465 SER A 169 REMARK 465 PHE A 170 REMARK 465 TYR A 171 REMARK 465 GLU A 172 REMARK 465 LEU A 173 REMARK 465 LYS A 174 REMARK 465 ASN A 175 REMARK 465 VAL A 176 REMARK 465 THR A 177 REMARK 465 ASN A 178 REMARK 465 ASN A 179 REMARK 465 PHE A 180 REMARK 465 ASP A 181 REMARK 465 GLU A 182 REMARK 465 ARG A 183 REMARK 465 PRO A 184 REMARK 465 ILE A 185 REMARK 465 SER A 186 REMARK 465 VAL A 187 REMARK 465 GLY A 188 REMARK 465 GLY A 189 REMARK 465 ASN A 190 REMARK 465 LYS A 191 REMARK 465 GLY A 203 REMARK 465 TYR A 204 REMARK 465 VAL A 205 REMARK 465 ASN A 206 REMARK 465 ASN A 207 REMARK 465 LYS A 213 REMARK 465 LYS A 214 REMARK 465 LEU A 215 REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 THR A 222 REMARK 465 THR A 223 REMARK 465 GLU A 224 REMARK 465 GLU A 225 REMARK 465 LEU A 226 REMARK 465 LYS A 227 REMARK 465 GLN A 228 REMARK 465 GLN A 229 REMARK 465 PHE A 230 REMARK 465 ASP A 231 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 SER A 460 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 SER B 460 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 337 C O CB CG CD OE1 OE2 REMARK 470 ALA A 459 C O CB REMARK 470 ALA B 217 C O CB REMARK 470 GLU B 337 C O CB CG CD OE1 OE2 REMARK 470 ALA B 459 C O CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 197 105.25 -176.97 REMARK 500 CYS A 240 -179.47 62.04 REMARK 500 GLN A 241 80.25 57.19 REMARK 500 ASP A 254 91.76 -64.77 REMARK 500 ASP A 311 47.45 -155.56 REMARK 500 GLU A 321 -34.04 -34.50 REMARK 500 ASP A 329 81.01 58.57 REMARK 500 ASP A 405 37.60 -91.29 REMARK 500 GLU A 406 23.00 30.26 REMARK 500 LYS A 417 46.25 -87.39 REMARK 500 THR A 458 47.54 -108.80 REMARK 500 PHE B 170 -53.16 -20.14 REMARK 500 ASP B 181 103.19 -52.96 REMARK 500 ASN B 206 -126.26 57.32 REMARK 500 ASP B 254 92.20 -64.62 REMARK 500 ASP B 311 47.47 -155.49 REMARK 500 ASP B 329 80.86 58.64 REMARK 500 ASP B 405 37.67 -91.25 REMARK 500 GLU B 406 22.68 30.38 REMARK 500 LYS B 417 46.45 -86.52 REMARK 500 THR B 458 47.07 -106.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6YD B 9901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5KX8 RELATED DB: PDB DBREF 5KX7 A 160 460 UNP Q9NWZ3 IRAK4_HUMAN 160 460 DBREF 5KX7 B 160 460 UNP Q9NWZ3 IRAK4_HUMAN 160 460 SEQRES 1 A 301 VAL SER ASP THR ARG PHE HIS SER PHE SER PHE TYR GLU SEQRES 2 A 301 LEU LYS ASN VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SEQRES 3 A 301 SER VAL GLY GLY ASN LYS MET GLY GLU GLY GLY PHE GLY SEQRES 4 A 301 VAL VAL TYR LYS GLY TYR VAL ASN ASN THR THR VAL ALA SEQRES 5 A 301 VAL LYS LYS LEU ALA ALA MET VAL ASP ILE THR THR GLU SEQRES 6 A 301 GLU LEU LYS GLN GLN PHE ASP GLN GLU ILE LYS VAL MET SEQRES 7 A 301 ALA LYS CYS GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY SEQRES 8 A 301 PHE SER SER ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL SEQRES 9 A 301 TYR MET PRO ASN GLY SER LEU LEU ASP ARG LEU SER CYS SEQRES 10 A 301 LEU ASP GLY THR PRO PRO LEU SER TRP HIS MET ARG CYS SEQRES 11 A 301 LYS ILE ALA GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU SEQRES 12 A 301 HIS GLU ASN HIS HIS ILE HIS ARG ASP ILE LYS SER ALA SEQRES 13 A 301 ASN ILE LEU LEU ASP GLU ALA PHE THR ALA LYS ILE SER SEQRES 14 A 301 ASP PHE GLY LEU ALA ARG ALA SER GLU LYS PHE ALA GLN SEQRES 15 A 301 TPO VAL MET TPO SEP ARG ILE VAL GLY THR THR ALA TYR SEQRES 16 A 301 MET ALA PRO GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SEQRES 17 A 301 SER ASP ILE TYR SER PHE GLY VAL VAL LEU LEU GLU ILE SEQRES 18 A 301 ILE THR GLY LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO SEQRES 19 A 301 GLN LEU LEU LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU SEQRES 20 A 301 GLU LYS THR ILE GLU ASP TYR ILE ASP LYS LYS MET ASN SEQRES 21 A 301 ASP ALA ASP SER THR SER VAL GLU ALA MET TYR SER VAL SEQRES 22 A 301 ALA SER GLN CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO SEQRES 23 A 301 ASP ILE LYS LYS VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 24 A 301 ALA SER SEQRES 1 B 301 VAL SER ASP THR ARG PHE HIS SER PHE SER PHE TYR GLU SEQRES 2 B 301 LEU LYS ASN VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SEQRES 3 B 301 SER VAL GLY GLY ASN LYS MET GLY GLU GLY GLY PHE GLY SEQRES 4 B 301 VAL VAL TYR LYS GLY TYR VAL ASN ASN THR THR VAL ALA SEQRES 5 B 301 VAL LYS LYS LEU ALA ALA MET VAL ASP ILE THR THR GLU SEQRES 6 B 301 GLU LEU LYS GLN GLN PHE ASP GLN GLU ILE LYS VAL MET SEQRES 7 B 301 ALA LYS CYS GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY SEQRES 8 B 301 PHE SER SER ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL SEQRES 9 B 301 TYR MET PRO ASN GLY SER LEU LEU ASP ARG LEU SER CYS SEQRES 10 B 301 LEU ASP GLY THR PRO PRO LEU SER TRP HIS MET ARG CYS SEQRES 11 B 301 LYS ILE ALA GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU SEQRES 12 B 301 HIS GLU ASN HIS HIS ILE HIS ARG ASP ILE LYS SER ALA SEQRES 13 B 301 ASN ILE LEU LEU ASP GLU ALA PHE THR ALA LYS ILE SER SEQRES 14 B 301 ASP PHE GLY LEU ALA ARG ALA SER GLU LYS PHE ALA GLN SEQRES 15 B 301 TPO VAL MET TPO SEP ARG ILE VAL GLY THR THR ALA TYR SEQRES 16 B 301 MET ALA PRO GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SEQRES 17 B 301 SER ASP ILE TYR SER PHE GLY VAL VAL LEU LEU GLU ILE SEQRES 18 B 301 ILE THR GLY LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO SEQRES 19 B 301 GLN LEU LEU LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU SEQRES 20 B 301 GLU LYS THR ILE GLU ASP TYR ILE ASP LYS LYS MET ASN SEQRES 21 B 301 ASP ALA ASP SER THR SER VAL GLU ALA MET TYR SER VAL SEQRES 22 B 301 ALA SER GLN CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO SEQRES 23 B 301 ASP ILE LYS LYS VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 24 B 301 ALA SER MODRES 5KX7 TPO A 342 THR MODIFIED RESIDUE MODRES 5KX7 TPO A 345 THR MODIFIED RESIDUE MODRES 5KX7 SEP A 346 SER MODIFIED RESIDUE MODRES 5KX7 TPO B 342 THR MODIFIED RESIDUE MODRES 5KX7 TPO B 345 THR MODIFIED RESIDUE MODRES 5KX7 SEP B 346 SER MODIFIED RESIDUE HET TPO A 342 11 HET TPO A 345 11 HET SEP A 346 10 HET TPO B 342 11 HET TPO B 345 11 HET SEP B 346 10 HET 6YD B9901 24 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM 6YD ~{N}-(3-AMINOCARBONYL-1-METHYL-PYRAZOL-4-YL)-6-(1- HETNAM 2 6YD METHYLPYRAZOL-4-YL)PYRIDINE-2-CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 4(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 6YD C15 H15 N7 O2 HELIX 1 AA1 GLU A 233 ALA A 238 1 6 HELIX 2 AA2 SER A 269 SER A 275 1 7 HELIX 3 AA3 CYS A 276 THR A 280 5 5 HELIX 4 AA4 SER A 284 ASN A 305 1 22 HELIX 5 AA5 THR A 351 MET A 355 5 5 HELIX 6 AA6 ALA A 356 ARG A 361 1 6 HELIX 7 AA7 THR A 365 GLY A 383 1 19 HELIX 8 AA8 LEU A 395 LEU A 397 5 3 HELIX 9 AA9 ASP A 398 ASP A 405 1 8 HELIX 10 AB1 THR A 409 ILE A 414 1 6 HELIX 11 AB2 ASP A 422 LEU A 437 1 16 HELIX 12 AB3 LYS A 440 ARG A 444 5 5 HELIX 13 AB4 ASP A 446 MET A 457 1 12 HELIX 14 AB5 PHE B 170 THR B 177 1 8 HELIX 15 AB6 THR B 223 CYS B 240 1 18 HELIX 16 AB7 SER B 269 CYS B 276 1 8 HELIX 17 AB8 LEU B 277 THR B 280 5 4 HELIX 18 AB9 SER B 284 ASN B 305 1 22 HELIX 19 AC1 LYS B 313 ALA B 315 5 3 HELIX 20 AC2 THR B 351 MET B 355 5 5 HELIX 21 AC3 ALA B 356 ARG B 361 1 6 HELIX 22 AC4 THR B 365 GLY B 383 1 19 HELIX 23 AC5 LEU B 395 LEU B 397 5 3 HELIX 24 AC6 ASP B 398 ASP B 405 1 8 HELIX 25 AC7 THR B 409 ILE B 414 1 6 HELIX 26 AC8 ASP B 422 LEU B 437 1 16 HELIX 27 AC9 LYS B 440 ARG B 444 5 5 HELIX 28 AD1 ASP B 446 THR B 458 1 13 SHEET 1 AA1 3 VAL A 210 ALA A 211 0 SHEET 2 AA1 3 CYS A 259 VAL A 263 -1 O TYR A 262 N ALA A 211 SHEET 3 AA1 3 LEU A 248 SER A 252 -1 N SER A 252 O CYS A 259 SHEET 1 AA2 2 HIS A 307 ILE A 308 0 SHEET 2 AA2 2 ARG A 334 ALA A 335 -1 O ARG A 334 N ILE A 308 SHEET 1 AA3 2 ILE A 317 LEU A 319 0 SHEET 2 AA3 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA4 2 VAL A 343 MET A 344 0 SHEET 2 AA4 2 GLU A 363 ILE A 364 -1 O ILE A 364 N VAL A 343 SHEET 1 AA5 6 HIS B 166 SER B 167 0 SHEET 2 AA5 6 LEU B 248 SER B 252 1 O LEU B 249 N HIS B 166 SHEET 3 AA5 6 CYS B 259 VAL B 263 -1 O CYS B 259 N SER B 252 SHEET 4 AA5 6 THR B 208 LYS B 214 -1 N LYS B 213 O LEU B 260 SHEET 5 AA5 6 VAL B 199 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA5 6 LYS B 191 GLU B 194 -1 N MET B 192 O VAL B 200 SHEET 1 AA6 2 HIS B 307 ILE B 308 0 SHEET 2 AA6 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA7 2 ILE B 317 LEU B 319 0 SHEET 2 AA7 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 SHEET 1 AA8 2 VAL B 343 MET B 344 0 SHEET 2 AA8 2 GLU B 363 ILE B 364 -1 O ILE B 364 N VAL B 343 LINK C TPO A 342 N VAL A 343 1555 1555 1.35 LINK C MET A 344 N TPO A 345 1555 1555 1.34 LINK C TPO A 345 N SEP A 346 1555 1555 1.34 LINK C SEP A 346 N ARG A 347 1555 1555 1.36 LINK C TPO B 342 N VAL B 343 1555 1555 1.35 LINK C MET B 344 N TPO B 345 1555 1555 1.35 LINK C TPO B 345 N SEP B 346 1555 1555 1.35 LINK C SEP B 346 N ARG B 347 1555 1555 1.36 CISPEP 1 GLU A 392 PRO A 393 0 -1.76 CISPEP 2 GLU B 392 PRO B 393 0 -1.83 SITE 1 AC1 9 MET B 192 ALA B 211 LYS B 213 VAL B 246 SITE 2 AC1 9 TYR B 262 VAL B 263 MET B 265 GLY B 268 SITE 3 AC1 9 LEU B 318 CRYST1 87.800 114.280 139.440 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011390 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008750 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007172 0.00000